{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:11:57Z","timestamp":1790075517290,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:00:00Z","timestamp":1402963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.rmed.2014.05.013","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T20:00:36Z","timestamp":1402084836000},"page":"1153-1162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Extrafine beclomethasone\/formoterol in severe COPD patients with history of exacerbations"],"prefix":"10.1016","volume":"108","author":[{"given":"J.A.","family":"Wedzicha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vestbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.","family":"Paggiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bonnet-Gonod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cohuet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2808-4184","authenticated-orcid":false,"given":"M.","family":"Corradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Petruzzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Agusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2014.05.013_bib1","unstructured":"The global burden of disease, 2004 update, World Health Organization. ISBN 978 92 4 156371 0. http:\/\/www.who.int\/healthinfo\/global_burden_disease\/GBD_report_2004update_full.pdf."},{"key":"10.1016\/j.rmed.2014.05.013_bib2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.05.013_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jamp.2009.0772","article-title":"Lung deposition of BDP\/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients","volume":"23","author":"De Backer W,Devolder","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"12","key":"10.1016\/j.rmed.2014.05.013_bib4","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.rmed.2010.09.008","article-title":"Beclomethasone\/formoterol in the management of COPD: a randomised controlled trial","volume":"104","author":"Calverley","year":"2010","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2014.05.013_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1183\/09031936.00207611","article-title":"A trial of beclomethasone\/formoterol in COPD using EXACT-PRO to measure exacerbations","volume":"41","author":"Singh","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.05.013_bib6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"issue":"5 Pt 1","key":"10.1016\/j.rmed.2014.05.013_bib7","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.rmed.2014.05.013_bib8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1164\/rccm.200310-1443OC","article-title":"Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease","volume":"169","author":"Wilkinson","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2014.05.013_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/rccm.200708-1290OC","article-title":"Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort","volume":"177","author":"Langsetmo","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.rmed.2014.05.013_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1164\/rccm.201005-0762OC","article-title":"Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary","volume":"183","author":"Leidy","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2014.05.013_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rmed.2014.05.013_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"Suppl. B","key":"10.1016\/j.rmed.2014.05.013_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0954-6111(06)80166-6","article-title":"The St. George's respiratory questionnaire","volume":"85","author":"Jones","year":"1991","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2014.05.013_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/09031936.00161507","article-title":"Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited","volume":"32","author":"Keene","year":"2008","journal-title":"ERJ"},{"key":"10.1016\/j.rmed.2014.05.013_bib15","article-title":"Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease","volume":"9","author":"Nannini","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmed.2014.05.013_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.2112055","article-title":"Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in the treatment of chronic obstructive pulmonary disease","volume":"116","author":"Mahler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2014.05.013_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/COPD.S27320","article-title":"Effects of mometasone furoate\/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week phase III trial in subjects with moderate-to-very severe COPD","volume":"7","author":"Doherty","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"10.1016\/j.rmed.2014.05.013_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2165\/00003495-200969050-00004","article-title":"Efficacy and tolerability of budesonide\/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease","volume":"69","author":"Rennard","year":"2009","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.rmed.2014.05.013_bib19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1096\/fsb2fj000432fje","article-title":"Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages","volume":"15","author":"K1","year":"2001","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.rmed.2014.05.013_bib20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1183\/09031936.04.00121404","article-title":"Impact of preventing exacerbations on deterioration of health status in COPD","volume":"23","author":"Spencer","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.05.013_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","article-title":"Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial","volume":"11","author":"Sethi","year":"2010","journal-title":"Respir Res"},{"issue":"8","key":"10.1016\/j.rmed.2014.05.013_bib22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.rmed.2008.04.019","article-title":"Effect of fluticasone propionate\/salmeterol (250\/50\u00a0\u03bcg) or salmeterol (50\u00a0\u03bcg) on COPD exacerbations","volume":"102","author":"Ferguson","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2014.05.013_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200707-973OC","article-title":"The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol\/fluticasone propionate or tiotropium bromide","volume":"177","author":"Wedzicha","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.rmed.2014.05.013_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1378\/chest.11-0281","article-title":"Influence of season on exacerbation characteristics in patients with COPD","volume":"141","author":"Donaldson","year":"2012","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2014.05.013_bib25","first-page":"1204","article-title":"Exacerbations of chronic pulmonary disease","volume":"48","author":"Wedzicha","year":"2003","journal-title":"Respir Care"},{"issue":"2","key":"10.1016\/j.rmed.2014.05.013_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.12-2308","article-title":"Detection of COPD exacerbations and compliance with patient-reported daily symptom diaries","volume":"144","author":"Johnston","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2014.05.013_bib27","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease","volume":"Vol. 164","author":"Seemungal","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rmed.2014.05.013_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1164\/rccm.200602-244OC","article-title":"Impact of salmeterol\/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease","volume":"175","author":"Kardos","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rmed.2014.05.013_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/15412550903140881","article-title":"Effect of fluticasone propionate\/salmeterol (250\/50) on COPD exacerbations and impact on patient outcomes","volume":"6","author":"Anzueto","year":"2009","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.rmed.2014.05.013_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.rmed.2011.07.020","article-title":"Effect of budesonide\/formoterol pMDI on COPD exacerbations: a double-blind, randomized study","volume":"106","author":"Sharafkhaneh","year":"2012","journal-title":"Respir Med"}],"updated-by":[{"DOI":"10.1016\/j.rmed.2015.01.016","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000}}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114002005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114002005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:30:30Z","timestamp":1760614230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611114002005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0954611114002005"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2014.05.013","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.rmed.2015.01.016","asserted-by":"object"}]},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrafine beclomethasone\/formoterol in severe COPD patients with history of exacerbations","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2014.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}